Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,144 | -15,214 | -8,480 | -33,971 | -26,129 |
| Depreciation Amortization | 167 | 106 | 45 | 266 | 195 |
| Accounts receivable | 786 | -3,599 | -2,092 | -1,405 | -2,088 |
| Accounts payable and accrued liabilities | -4,904 | 539 | -75 | 1,854 | 3,650 |
| Other Working Capital | -2,903 | -1,599 | -2,028 | 1,288 | 2,433 |
| Other Operating Activity | 5,847 | 4,267 | 2,753 | 3,494 | 1,847 |
| Operating Cash Flow | $-21,151 | $-15,500 | $-9,877 | $-28,474 | $-20,092 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -4 | -3 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $-4 | $-3 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 36,331 | 2,337 | 1,460 | 24,432 | 12,856 |
| Other Financing Activity | -366 | -289 | -164 | -867 | -672 |
| Financing Cash Flow | $35,965 | $2,048 | $1,296 | $23,565 | $12,184 |
| Beginning Cash Position | 25,009 | 25,009 | 25,009 | 29,922 | 29,922 |
| End Cash Position | 39,823 | 11,557 | 16,428 | 25,009 | 22,011 |
| Net Cash Flow | $14,814 | $-13,452 | $-8,581 | $-4,913 | $-7,911 |
| Free Cash Flow | |||||
| Operating Cash Flow | -21,151 | -15,500 | -9,877 | -28,474 | -20,092 |
| Capital Expenditure | N/A | N/A | N/A | -4 | -3 |
| Free Cash Flow | -21,151 | -15,500 | -9,877 | -28,478 | -20,095 |